About This Comparison
Our Editorial Standards
This hims vs mate provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Mate vs hims 2026: Budget Alternative vs Proven Excellence
Mate and hims both provide men's health telehealth for ED and hair loss but differ dramatically in operational maturity, service scope, and pricing philosophy: hims operates as established market leader (7+ years, 2M+ customers) providing complete platform ($25-295/month) across ED, hair loss, skincare, mental health, weight management, and primary care with extensive medication formulary and proven track record, while Mate positions as emerging budget startup (<3 years operational history) offering basic ED and hair loss treatment ($29-149/month) with generic-only medications, limited services, and uncertain long-term viability. This comparison examines whether hims complete platform and operational maturity justify premium pricing or Mate budget positioning delivers equivalent value.
Platform Overview
Platform Maturity and Scale
Treatment Categories
Medication Options
Pricing Comparison
Platform Features
How We Tested Hims vs Mate
Our Comparison Methodology
This comparison is based on complete analysis of platform maturity, treatment categories, medication options, pricing structures, and platform features, supplemented by peer-reviewed research on telehealth quality and PE treatment.
Clinical Evidence: Treatment recommendations reference FDA-approved medication prescribing information (FDA Sertraline Label), PE treatment guidelines from the American Urological Association, and clinical efficacy data from The Journal of Sexual Medicine.
Research Foundation: We analyzed peer-reviewed studies including SSRI efficacy from BJU International, telehealth platform quality from JAMA Network Open, and multi-category platform patient outcomes.
Pricing Analysis: All pricing reflects published rates as of January 2026, verified through official platform websites.
Service Verification: Platform capabilities, provider credentials, operational history, and service quality were evaluated through detailed review of company disclosures and regulatory documentation.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed treatment decisions.
Final Verdict: Hims vs Mate
Choose Mate if: You exclusively need basic ED or hair loss treatment with generic medications, prioritize minimal costs ($348-1,068/year) saving $200-500 annually compared to hims, accept limited formulary and basic consultation model, can tolerate startup platform risks regarding long-term viability, don't require multi-category health services or sophisticated platform features, or make purchasing decisions based primarily on lowest pricing accepting reduced medical support and operational uncertainty.
Choose hims if: You want complete men's health platform addressing ED, hair loss, skincare, mental health, weight management, or multiple concurrent conditions; prioritize platform maturity and operational reliability (7+ years, 2M+ customers); seek superior medical oversight with unlimited physician messaging and ongoing support; need brand-name medication options or premium formulations; value sophisticated platform features including mobile apps and health dashboard; or prioritize long-term medication supply reliability and proven track record despite higher costs ($300-3,540/year).
Bottom line: Mate and hims both provide effective men's health treatment using FDA-approved generic medications with comparable clinical efficacy for shared active ingredients. hims operates as established complete platform ($300-3,540/year) serving 2M+ customers with extensive medication options, superior medical support, multi-category consolidation, and proven 7+ year track record justifying premium pricing through reliability and features. Mate positions as emerging budget startup ($348-1,068/year) offering basic generic prescriptions with minimal services, limited track record (<3 years), and uncertain long-term viability. For patients prioritizing cost savings and accepting startup risks, Mate delivers $200-500 annual savings. For patients valuing operational maturity, complete care, superior medical oversight, and multi-year medication reliability, hims justifies premium through established credibility and sophisticated platform. Platform longevity and service quality favor hims; aggressive pricing favors Mate with associated startup risks.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- GoodRx - ED Medication Pricing GuideCost comparison of erectile dysfunction medications and generics
- American Telemedicine Association - Why TelemedicineATA overview of telemedicine benefits and effectiveness data
- FDA - Safe Online Prescription Medicine ChecklistFDA consumer safety checklist for purchasing prescription medication online
- American College of Cardiology - Sexual Activity & CVDACC guidance on sexual activity and cardiovascular disease risk
- FDA Prescribing Information (NDA 20895)Official FDA-approved prescribing information and drug labeling
- International Journal of Impotence ResearchNature-published journal on erectile function and male sexual health
- PubMed - Massachusetts Male Aging StudyLandmark epidemiological study on ED prevalence and risk factors
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
